We used the amplification refractory mutation system (ARMS)-a polymerase-chain-reaction-based methodto determine the 3206 T-to-G polymorphism on exon 4 of the apolipoprotein (apo) C Ill gene. Apo C Ill is an inhibitor of the enzyme lipoprotein lipase (EC 3.1.1.34).
between the hypertriglyceridemic and control individuals. We also determined the presence of the Sad site at nucleotide 3175 in these same individuals and found no significant difference in Sad genotypes between the two groups. This study reaffirms the usefulness of ARMS as a simple, reliable method for detecting mutations and polymorphisms in clinical and epidemiological studies.
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Hypertriglyceridemia is one of the commonest forms of hyperlipidemia.
Although it is stifi unclear whether high serum triglyceride concentrations represent an independent risk factor, increased triglyceride concentrations are responsible for changes in several lipoproteins, which in turn increase the risk of hypertriglyceridemic individuals to coronary artery disease (1, 2). Three proteins are known to be important in the catabolism of chylomicron and very-low-density lipoprotein (VLDL), two triglyceride-rich lipoproteins: lipoprotein lipase (LPL; EC 3.1.1.34) and apolipoproteins C II and C III (apo CII and III) (3, 4)4 LPL removes triglycerides from chylomicron and VLDL to form chylomicron and VLDL remnants, respectively. Ape C II is required for the activation of LPL, whereas ape C III modulates this process through its inhibitory effect on LPL. Thus, increased ape C III concentrations may be associated with 
hypertriglyceridemia-a finding
that has recently been demonstrated in a transgenic mouse model (5). The apo C ifi gene is composed of 4 exons coding for a mature protein of 79 amino acids. Most of the coding information is contained in exon 4(6). Several reports suggest the possible association of hypertriglyceridemia with a polymorphic site in the 3'-untranslated region of exon 4 of the ape C ill gene (7) (8) (9) . This polymorphism, a C-to-G has been used to identify point mutations in many systems. ARMS is based on the observation that primers used in PCR., when mismatched in the last base at the 3' end, will not lead to amplification.
To detect a single base substitution, two sense primers differing only in a single base at the 3' end are used. One of the sense primers matches with the more common or wild-type allele, the other with the mutant or polymorphic allele. A common antisense primer is used for both reactions. DNA with either the wild or polymorphic-type sequences is amplified by the matching primer, whereas heterozygnus carriers are amplified by both types of primers.
With the ARMS method, we determined the optimal conditions for detecting the T/G polymorphism at nudeotide 3206 of the ape C III gene. We then used this method to compare the frequency of polymorphisms at nucleotide 3206 in normal and hypertriglyceridemic individuals. By using restriction endonuclease digestion, we also compared the frequency of polymorphisms at nucleotide 3175 in the same groups of individuals. 
MaterIals and Methods
Study Population
DNA Preparation
Genomic DNA was extracted from peripheral leukocytea isolated from EDTA-anticoagulated blood with a commercially available DNA isolation kit (Puregene; Gentra Systems, Minneapolis, MN).
Oligonucleotide Primers
The oligonucleotide primers used for ARMS were synthesized on a DNA synthesizer (Model ABI 394; Applied Biosystems, Foster City, CA) by the Microchemical Facility at the University of Minnesota and purified by HPLC. Since T is the more common base at nucleotide 3206 in our control population, it is defined as the wild genotype. The sequence of the allele-specific sense primer for the wild genotype was 5'CTTGGGTCCTGCAATCT-CCAGGGCCT3'; that for the polymorphic allele was 5'CTFGGGTCCTGCAATCTCCAGGGCCG3'.
The common (antisense) primer was 5'GGGAGGCCAGCAT-GCCTGGAG3'.
The PCR product generated from this reaction is a 115 base-pair (bp) fragment.
To prove the reliability and reproducibility of each assay, we used as an internal control primers spanning a 208-bp fragment of exon 3 of the apo C ifi gene. The sequence of the sense primer was 5'CCGATCCACCCCACTCAGCC3 ' and that of the antisense primer was 5'GAATGGAGGCAGCTG-GCAG3' (6).
ARMS Analysis
Two PCR reactions were performed for each sample: The sense primer specific for the wild-type allele was used in one and the sense primer specific for the polymorphic allele was used in the other. The common antisense primer, as well as the sense and antisense internal control primers, were added to both reactions. PCR reactions were carried out with 1 ug of genomic DNA and 2.5 U of AmpliTaq DNA polymerase (Perkun-Elmer Cetus, Norwalk, CT) in a reaction volume of 100 1L, containing 10 mmol/L Tris (pH 8.3), 1.0 mmol/L MgC12, 50 mmoIJL KC1, 0.2 mmol/L of all four deoxynucleoside triphosphates, and 0.5 pmol/L of each of the five primers.
To avoid evaporation, the reaction mixture was overlaid with miiieral oil. Reactions were carried out with a Twin Block thermal cycler (Ericomp, San Diego, CA). The amplification cycles were: denaturation at 95#{176}C for 5 mm, primer annealing at 62#{176}C for 75s, and primer extension at 72#{176}C
for 120 s; 30 cycles of denaturation at 95#{176}C for 1 miii, primer annealing at 62#{176}C for 45 s, and primer extension at 72#{176}C for 75 s; and then one cycle of denaturation at 95#{176}C for 1 miii, primer annealing at 62#{176}C for 45 s, and primer extension at 72#{176}C for 7 miii.
Detection of Amplification Products
We added 3 L of Ficoll loading dye (2.5 g/L bromphenol blue and xylene cyanol in 150 g/L Ficoll) to 15 &L of PCR product. The mixture was electrophoresed for 30 mm at 150 V on a 3% agarose gel ( 
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Ox 174 Table 2 shows the nucleotide sequences of three sets of sense primers used and the normal DNA sequence of the human ape C Ill gene fragment studied. In ARMS, the degree of refractoriness depends much on the type of mismatch at the 3'-OH-terminal nucleotide and at the nucleotide adjacent to the 3'-terminal end, with purine! purine and pyrimidine/pyrimidine mismatches being more refractory to amplification than purine/pyrimidine mismatches (11-13). With our primers, the mismatch at the 3'-terminal end between the wild-type primer and polymorphic allele was A/G, or purine/purine, whereas that between the polymorphic primer and normal allele was CIT, or pyrimidune/pyrimidine. To study allele specificity of our primers, we generated additional mismatches at the nucleotide adjacent to the 3'-terminal end. In the first set of primers (Table 2) , the penultimate base at the 3' end was not altered. !n the second set, the penultimate base at the 3' end of both primers was altered to substitute a C for T, generating a template! primer A/C, or purine/pyriinidine, mismatch.
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In the third set, the penultimate base at the 3' end of both primers was altered to substitute a G for T, creating a template/primer MG, or purune/purine, mismatch. The first and second sets of primers gave rise to 108-and 115-bp amplification products, respectively. No amplification product, except for the internal control, was visible with the third set of primers. The second set of primers was chosen for use in this study to assure the required specificity.
ARMS Analysis of Homozygotes
and Heterozygotes Figure 1 shows the electrophoretic pattern of ARMS analysis of three individuals homozygous for T, homozygnus for G, or heterozygous at nudeotide 3206. The T/T homozygote (lanes 2 and 3) and G/G homozygote (lanes 4 and 5) each produced a 115-bp band only in lanes where the respective allele-specific sense primer was used, whereas a GIT heterozygote produced bands with both primers (lanes 6 and 7) . The 208-bp internal control band was visible in all lanes. Table 3 shows the frequency of the T1T, GIG, and GPF ape C III genotypes with respect to nucleotide 3206 in 46 control and 45 hypertriglyceridemic individuals. Within the control group we did not find a significant difference in genotypes between men and women.
ARMS Analysisof Controland Hypertnglyceridemic Individuals
There was an overall significant difference (P <0.01) in genotyping between control and hypertriglyceridemic individuals.
When the data were further analyzed to determine the specific differences, hypertriglyceridemic individuals were significantly lower (P <0 'Genotypes between control and hypertrlglyceridernic indMduals are signiflcantly different (P <0.01) by x2test genotypes than controls. No significant differences were found between GIG and GPF genotypes.
The data were also analyzed to determine if there was any association between the three genotypes and cholesterol, triglyceride, HDL-cholesterol, and LDL-cholesterol values. There was no significant difference between TPF, GIG, and GiT genotypes for any of these analytes in either the control or hypertriglyceridemic groups [by one-factor analysis of variance (ANOVA)].
Analysis by Sad Digestion
We determined the frequency of the ape C III genotypes with respect to nucleotide 3175 in the 46 control and 45 hypertriglyceridemic individuals by using Sac! restriction endonuclease digestion (Table 4) two bands of 190 bp and 116 bp were seen in agarose gel in addition to the 306-bp product.
As Table 4 shows, a greater percentage of control individuals did not have the Sac! site as compared with the hypertriglyceridemic individuals; however, the difference was not significant.
Only one individual (with triglyceride of 4.7 mmol/L) was homozygous for this polymorphism.
The data were further analyzed to determine if there was any association between the three Sac! genotypes and concentrations of cholesterol, triglyceride, HDLcholesterol, and LDL-cholesterol. There was no significant difference between the genotypes for any of these analytes in either the control or hypertriglyceridemic groups (by one-factor ANOVA). in the nucleotide next to the 3'-terminal end of the primers has been deliberately introduced to increase refractoriness and ensure specificity. As demonstrated here, when a second .AJG (purine/purine) mismatch was introduced at the penultimate base in addition to the purine/purine or pyrimidine/pyri.midine mismatch at the 3'-OH-terminal (as in the third set of primers), the primers did not produce a product with either allele because the additional purine/purine mismatch was too refractory; therefore, if a second mismatch at the penultimate base is introduced for added specificity, a less refractory purinelpyrimidine (as in the second set of primers) or pyrimidine/purine mismatch is the appropriate choice.
Association of
In our study of 46 control and 45 hypertriglyceridemic age-matched individuals, there was a significant difference between the two groups with respect to the frequencies of the two alleles at position 3206. In the control group, the T and G alleles were present with a frequency of 68.5% and 3 1.5%, respectively.
In contrast, in the hypertriglyceridemic group the 3206 T allele and 3206 G allele both had a prevalence of -50%. ' We also determined the frequency of the 3175 polyndrphism in the same control and hypertriglyceridemic grpnps, and found no significant differences among the tl'wee Sad genotypes in the two groups. This may be because the group we studied was predominantly Caucasian. Tas (7) has shown a strong association between hypertriglyceridemia and the Sac! (+) allele in Arabs in Kuwait.
We found no significant difference in either the hypertriglyceridemic or control group between the ape C III genotypes with respect to either nucleotide 3206 or 3175 and the values of cholesterol, triglyceride, HDLcholesterol, LDL-cholesterol, or ape C I!!. This may be due to the small number of subjects studied.
'While there is a statistically significant enrichment of 3206 G allele in the hypertriglyceridemic group as ipared with the control group, the significance of this -ing is not currently known. Also, it is not clear #{149}her homozygosity for the G-to-T substitution at !!allele is required for the individual's predisposition w hypertriglyceridemia.
Like the Sad allele, which involves a polymorphic site at nucleotide 3175, the polymorphism at 3206 resides in the 3'-end untranslated region of exon 4 of the ape C III gene. Whether this polymorphism may be directly involved in the regulation of ape C Ill gene or is a linkage marker to genes that predispose individuals to hypertriglyceridemia requires further study. As in the case of the Sad allele, it is possible that the association of the polymorphism with hypertriglyceridemia may vary in different ethnic populations, and additional dietary factors may increase or decrease this association.
In conclusion,
we have successfully used ARMS to study the second known polymorphism in exon 4 of the ape C III gene, thus confirming the usefulness and ease with which this PCR application can be used for the screening of known mutations and polymorphisms.
The association of the polymorphism at nucleotide 3206 with hypertriglyceridemia needs confirmation in large epidemiological studies.
